RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sensyne Health Stock

Sensyne Health Stocks 2024

Sensyne Health Stocks

139.22 M

Ticker

SENS.L

ISIN

GB00BYV3J755

WKN

A2N38D

In 2024, Sensyne Health had 139.22 M outstanding stocks, a 0% change from the 139.22 M stocks in the previous year.

The Sensyne Health Stocks history

YEARNUMBER OF STOCKS (undefined GBP)
2026e139.22
2025e139.22
2024e139.22
2023e139.22
2022e139.22
2021139.22
2020129.24
2019119.02
201894.78

Sensyne Health shares outstanding

The number of shares was Sensyne Health in 2023 — This indicates how many shares 139.22 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Sensyne Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sensyne Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sensyne Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sensyne Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Sensyne Health Aktienanalyse

What does Sensyne Health do?

Sensyne Health PLC is a British company specializing in artificial intelligence (AI) and digital health solutions. It was founded in 2018 and is headquartered in Oxford, UK. History: Sensyne Health was founded by Lord Drayson, a British entrepreneur and former Minister for Science and Innovation. The company is based on the belief that the application of AI technologies in the healthcare industry can help improve medical care, make the healthcare system more efficient, and ultimately save lives. Business model: Sensyne Health offers a range of products and services based on AI technologies. The key business areas include: - Clinical research: Sensyne Health works closely with national health authorities and various hospitals to collect and analyze data that can be used in the development of new treatment options and the improvement of diagnostic processes. - Digital patient monitoring: The company develops advanced sensors and devices that allow doctors and nurses to monitor the health status of patients in real-time. By using AI algorithms, health problems can be detected and treated early. - AI-based analysis: Sensyne Health has extensive experience in applying AI technologies to medical data. The company uses its expertise to conduct complex data analysis that helps doctors and researchers gain new insights into diseases and their treatment options. Products: Sensyne Health offers a variety of products and solutions tailored to the needs of the healthcare industry. Here are some of the key products that the company offers: - Patient data platform: A cloud-based platform that allows hospitals and research institutions to collect, store, and analyze patient data. The use of AI algorithms automates and accelerates data analysis. - Hospital collaborations: Sensyne Health works with various hospitals in the UK and other countries to collect and analyze patient data. The data is then shared in anonymized form with researchers and life science companies to develop new insights and treatment options. - AI-based patient monitoring: Sensyne Health has developed a range of devices and sensors that allow doctors and nurses to monitor the health status of patients in real-time. The data is automatically evaluated, and the results are transmitted to the medical staff to quickly respond to changes in the patient's condition. Conclusion: Sensyne Health is a leading provider of AI-based solutions for the healthcare industry. The company specializes in data collection, analysis, and the development of new treatment options. Through its collaborations with hospitals and government agencies, Sensyne Health has access to a large amount of data that can lead to new insights and improve medical care in the future. Answer: Sensyne Health PLC is a British company specializing in artificial intelligence (AI) and digital health solutions. It was founded in 2018 and is headquartered in Oxford, UK. The company was founded by Lord Drayson, and it aims to use AI technologies to improve medical care, make healthcare more efficient, and save lives. Sensyne Health offers products and services in clinical research, digital patient monitoring, and AI-based analysis. The company's products include a patient data platform, collaborations with hospitals, and AI-based patient monitoring devices. Sensyne Health is focused on collecting and analyzing data to develop new treatment options and improve healthcare in the future. Sensyne Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Sensyne Health's Shares Outstanding

Sensyne Health's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Sensyne Health’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Sensyne Health’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Sensyne Health’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Sensyne Health stock

How many stocks are there of Sensyne Health?

The current number of stocks of Sensyne Health is 139.22 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Sensyne Health are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Sensyne Health evolved in recent years?

The number of shares of Sensyne Health has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Sensyne Health as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Sensyne Health?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Sensyne Health pay?

Over the past 12 months, Sensyne Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sensyne Health is expected to pay a dividend of 0 GBP.

What is the dividend yield of Sensyne Health?

The current dividend yield of Sensyne Health is .

When does Sensyne Health pay dividends?

Sensyne Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sensyne Health?

Sensyne Health paid dividends every year for the past 0 years.

What is the dividend of Sensyne Health?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sensyne Health located?

Sensyne Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sensyne Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sensyne Health from 12/7/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 12/7/2024.

When did Sensyne Health pay the last dividend?

The last dividend was paid out on 12/7/2024.

What was the dividend of Sensyne Health in the year 2023?

In the year 2023, Sensyne Health distributed 0 GBP as dividends.

In which currency does Sensyne Health pay out the dividend?

The dividends of Sensyne Health are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sensyne Health

Our stock analysis for Sensyne Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sensyne Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.